The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a stern warning to healthcare professionals, pharmaceutical distributors, and the general public about the growing circulation of substandard and falsified insulin syringes in the market. The regulatory body raised alarms over the potential dangers these fake medical products pose to diabetic patients and others who rely on insulin injections for survival.
Insulin syringes are a critical medical tool for diabetes management, ensuring precise dosage delivery to regulate blood
